Topics

Trial Tests CRISPR Gene-Editing to Treat Sickle Cell Disease

15:00 EDT 31 Jul 2019 | Drugs.com

WEDNESDAY, July 31, 2019 -- A U.S. clinical trial of CRISPR gene-editing to treat people with sickle cell disease is underway. The trial seeks to recruit up to 45 adults with severe sickle cell disease. It will use CRISPR in an attempt to boost...

Original Article: Trial Tests CRISPR Gene-Editing to Treat Sickle Cell Disease

NEXT ARTICLE

More From BioPortfolio on "Trial Tests CRISPR Gene-Editing to Treat Sickle Cell Disease"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...